Literature DB >> 15946283

Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.

Sue Nikoletti1, Susan Hyde, Thérèse Shaw, Helen Myers, Linda J Kristjanson.   

Abstract

AIMS AND
OBJECTIVES: The study aimed to compare the use of plain ice, flavoured ice and standard care, to evaluate the effect on mucositis and to determine patients' perceptions of the two forms of oral cryotherapy.
BACKGROUND: Despite evidence that oral cryotherapy is useful in preventing mucositis in patients receiving 5-fluorouracil, concerns have been expressed about its clinical utility, due to potential side effects and negative perceptions.
DESIGN: A randomized, controlled, crossover trial was conducted in the outpatient chemotherapy department of an acute care teaching hospital in Perth, Western Australia. Patients were randomized to receive each of three interventions across three cycles of chemotherapy: standard care alone; standard care plus plain ice; and standard care plus flavoured ice.
METHODS: Oral mucositis was assessed by nurses prior to each of the three chemotherapy cycles and 15 days after each intervention. Two assessment tools were used, the Oral Assessment Guide, and the Western Consortium Cancer Nursing Research Scale. Participants completed a questionnaire to determine their comfort and satisfaction with oral cryotherapy, as well as factors affecting compliance.
RESULTS: Findings from 67 patients revealed that when participants used standard care alone, they were significantly more likely to experience symptoms of mucositis than when they used either plain or flavoured ice. Odds ratios were at least threefold higher for standard care alone, varying according to the instrument used. The two main concerns reported were the taste of flavoured ice and the time required to complete the cryotherapy interventions. Side effects such as nausea, sensitivity and headache were reported more frequently for flavoured ice (n = 11) compared with plain ice (n = 5) and standard care (n = 1).
CONCLUSIONS: Both forms of oral cryotherapy were effective in reducing the severity of oral mucositis after chemotherapy and were more effective than standard care alone. Flavoured ice was associated with the highest frequency of side effects. RELEVANCE TO CLINICAL PRACTICE: The benefits of cryotherapy appear to outweigh the problems in this sample of patients. The intervention should be tailored to individual patients, based on preferences for plain versus flavoured ice and small chips vs. larger blocks. Unsweetened frozen fruit juices should be evaluated. Time constraints could be addressed by providing transportable containers of ice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15946283     DOI: 10.1111/j.1365-2702.2005.01156.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  10 in total

Review 1.  Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Authors:  Helen V Worthington; Jan E Clarkson; Gemma Bryan; Susan Furness; Anne-Marie Glenny; Anne Littlewood; Martin G McCabe; Stefan Meyer; Tasneem Khalid
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 2.  Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy.

Authors:  Douglas E Peterson; Kerstin Ohrn; Joanne Bowen; Monica Fliedner; Judith Lees; Charles Loprinzi; Takehiko Mori; Anthony Osaguona; Dianna S Weikel; Sharon Elad; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2012-09-21       Impact factor: 3.603

Review 3.  Supportive cryotherapy: a review from head to toe.

Authors:  Kunal C Kadakia; Shaina A Rozell; Anish A Butala; Charles L Loprinzi
Journal:  J Pain Symptom Manage       Date:  2013-11-07       Impact factor: 3.612

4.  Chamomile infusion cryotherapy to prevent oral mucositis induced by chemotherapy: a pilot study.

Authors:  Paula Elaine Diniz Dos Reis; Marcia A Ciol; Nilce Santos de Melo; Paulo Tadeu de Souza Figueiredo; André Ferreira Leite; Natália de Melo Manzi
Journal:  Support Care Cancer       Date:  2016-05-17       Impact factor: 3.603

Review 5.  North Central Cancer Treatment Group--achievements and perspectives.

Authors:  Axel Grothey; Alex A Adjei; Steve R Alberts; Edith A Perez; Kurt A Jaeckle; Charles L Loprinzi; Daniel J Sargent; Jeff A Sloan; Jan C Buckner
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

6.  Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines.

Authors:  M Elvira P Correa; Karis Kin Fong Cheng; Karen Chiang; Abhishek Kandwal; Charles L Loprinzi; Takehiko Mori; Carin Potting; Tanya Rouleau; Juan J Toro; Vinisha Ranna; Anusha Vaddi; Douglas E Peterson; Paolo Bossi; Rajesh V Lalla; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-12-14       Impact factor: 3.603

7.  Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.

Authors:  Mustafa Ozturk; Seref Komurcu; Selim Kilic; Ahmet Ozet; Fikret Arpaci; Bekir Ozturk; Okan Kuzhan; Selmin Ataergin
Journal:  Support Care Cancer       Date:  2009-02-06       Impact factor: 3.603

Review 8.  Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy.

Authors:  Philip Riley; Anne-Marie Glenny; Helen V Worthington; Anne Littlewood; Jan E Clarkson; Martin G McCabe
Journal:  Cochrane Database Syst Rev       Date:  2015-12-23

Review 9.  Treatment of oral mucositis due to chemotherapy.

Authors:  Begonya Chaveli-López; José V Bagán-Sebastián
Journal:  J Clin Exp Dent       Date:  2016-04-01

Review 10.  Prevention and treatment of oral mucositis in patients receiving chemotherapy.

Authors:  Carlos Alvariño-Martín; Maria G Sarrión-Pérez
Journal:  J Clin Exp Dent       Date:  2014-02-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.